Skip to main
INMD

Inmode Ltd (INMD) Stock Forecast & Price Target

Inmode Ltd (INMD) Analyst Ratings

Based on 4 analyst ratings
Hold
Strong Buy 0%
Buy 25%
Hold 75%
Sell 0%
Strong Sell 0%

Bulls say

InMode Ltd achieved a notable increase in its global installed base, selling 971 systems in the second quarter of 2025, resulting in a total of approximately 28,855 units, with around 12,347 units in the U.S., reflecting a 3.4% growth from the prior quarter. The company reported an operating margin of 27.5%, surpassing estimates and marking a 40 basis point improvement year-over-year. Additionally, the robust domestic sales of $49.7 million demonstrated a 9% growth, further emphasizing the expanding potential within the aesthetic market driven by rising consumer and physician interest.

Bears say

InMode Ltd faces a negative outlook primarily due to anticipated contraction in its profit margins, despite currently holding high margins within the med tech sector. Additionally, the company's earnings per share (EPS) growth is projected to lag behind revenue growth, contributing to investor concerns. Furthermore, a bear case scenario suggests a compound annual growth rate (CAGR) of less than 5% over the coming years, driven by underwhelming growth from existing products and slow adoption of new offerings.

Inmode Ltd (INMD) has been analyzed by 4 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 25% recommend Buy, 75% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inmode Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inmode Ltd (INMD) Forecast

Analysts have given Inmode Ltd (INMD) a Hold based on their latest research and market trends.

According to 4 analysts, Inmode Ltd (INMD) has a Hold consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inmode Ltd (INMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.